Cancer

CHICAGO — Savolitinib, alone or in combination with durvalumab, did not demonstrate significant efficacy in patients with advanced clear cell renal cancer, according to a presentation at ASCO Annual Meeting.

CHICAGO —Cabozantinib did not significantly extend progression-free survival in patients with metastatic urothelial carcinoma who had undergone platinum-based chemotherapy, according to data presented at ASCO Annual Meeting.

Tofacitinib shows no evidence of an increased risk for malignancies compared with TNF inhibitors when used to treat rheumatoid arthritis, according to data published in Arthritis & Rheumatology.

Despite strides in cancer care and treatment, disparities in breast cancer outcomes still remain for women of color when compared with white women.

Black patients were less likely to receive quality oncologic treatment for gastrointestinal tract cancers compared with white patients, according to a study published in JAMA Network Open.

In a Healio video exclusive, Chris Evans, president of the Colon Cancer Coalition and Healio’s 2021 Patient Voice Disruptive Innovator, shares updates on the organization’s recent accomplishments and future plans.

Patients with cancer undergoing treatment with immune checkpoint inhibitors did not experience exacerbations in their asthma, according to a study published in Annals of Allergy, Asthma & Immunology.

ATLANTA — Researchers observed that PCI in patients with cancer is safe, regardless of cancer type or concomitant thrombocytopenia, and its use increased over time.

Between 2012 and 2019, esophageal cancer rates nearly doubled and prevalence of Barrett’s esophagus increased by 50% among adults aged 45 to 64 years, according to researchers.

SAN DIEGO — Among nearly 4,000 adults with five common types of cancer plus diabetes, diabetes did not affect overall cancer survival, and cancer did not worsen glycemic control, according to study data.